Study on the Safety and Efficacy of Intratumoral Administration of IDOV-SAFETM in the Treatment of Advanced Solid Tumors
NCT06713148
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
NOT_YET_RECRUITING
Status
42
Enrollment
OTHER
Sponsor class
Conditions
Advanced Malignant Solid Tumor
Interventions
BIOLOGICAL:
IDOV-SAFETM
Sponsor
Fudan University